Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10221902 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn RO4929097 in Children With Relapsed/Refractory Solid or CNS Tumors, Lymphoma, or T-Cell Leukemia
Conditions: Lymphoma;   Brain Neoplasms;   Sarcoma;   Osteosarcoma;   Wilm's Tumor
Interventions: Drug: RO4929097;   Drug: Dexamethasone

Indicates status has not been verified in more than two years